{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:20:18Z","timestamp":1752229218464},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00774-018-00985-8","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T01:48:48Z","timestamp":1552441728000},"page":"864-870","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictive factors for the efficacy of denosumab in postmenopausal Japanese women with non-metastatic breast cancer receiving adjuvant aromatase inhibitors: a combined analysis of two prospective clinical trials"],"prefix":"10.1007","volume":"37","author":[{"given":"Katsuhiko","family":"Nakatsukasa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"985_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00198-009-0970-6","volume":"1","author":"T Suzuki","year":"2010","unstructured":"Suzuki T, Yoshida H (2010) Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women. Osteoporos Int 1:71\u201379","journal-title":"Osteoporos Int"},{"key":"985_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00001648-199103000-00005","volume":"2","author":"ES Fisher","year":"1991","unstructured":"Fisher ES, Baron JA, Malenka DJ, Barrett JA, Kniffin WD, Whaley FS, Bubolz TA (1991) Hip fracture incidence and mortality in New England. Epidemiology 2:116\u2013122","journal-title":"Epidemiology"},{"key":"985_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2105\/AJPH.79.3.274","volume":"79","author":"J Magaziner","year":"1989","unstructured":"Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE (1989) Survival experience of aged hip fracture patients. Am J Public Health 79:274\u2013278","journal-title":"Am J Public Health"},{"key":"985_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF02484420","volume":"18","author":"RP Pitto","year":"1994","unstructured":"Pitto RP (1994) The mortality and social prognosis of hip fractures. A prospective multifactorial study. Int Orthop 18:109\u2013113","journal-title":"Int Orthop"},{"key":"985_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00774-005-0654-z","volume":"24","author":"S Muraki","year":"2006","unstructured":"Muraki S, Yamamoto S, Ishibashi H, Nakamura K (2006) Factors associated with mortality following hip fracture in Japan. J Bone Miner Metab 24:100\u2013104","journal-title":"J Bone Miner Metab"},{"key":"985_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s002239900513","volume":"63","author":"C Johansson","year":"1998","unstructured":"Johansson C, Black D, Jonell O, Oden A, Mellstrom D (1998) Bone mineral density is a predictor of survival. Calcif Tissue Int 63:190\u2013196","journal-title":"Calcif Tissue Int"},{"key":"985_CR7","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/archinte.159.11.1215","volume":"159","author":"DM Kado","year":"1999","unstructured":"Kado DM, Browner WS, Palemo L, Nevitt MC, Genant HK, Cummings SR (1999) Vertebral fractures and mortality in older women. Arch Int Med 159:1215\u20131220","journal-title":"Arch Int Med"},{"key":"985_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1532-5415.2000.tb02641.x","volume":"48","author":"KE Ensruud","year":"2000","unstructured":"Ensruud KE, Thompson DE, Cauley JA, Nevitt MC, Kado DM, Hochoberg MC, Santora AC, Black DM (2000) Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. J Am Geriat Soc 48:241\u2013249","journal-title":"J Am Geriat Soc"},{"key":"985_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s001980170114","volume":"12","author":"DP Trivedi","year":"2001","unstructured":"Trivedi DP, Khaw KT (2001) Bone mineral density at the hip predicts mortality in elderly men. Osteoporos Int 12:259\u2013265","journal-title":"Osteoporos Int"},{"key":"985_CR10","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1359\/jbmr.070412","volume":"22","author":"ND Nguyen","year":"2007","unstructured":"Nguyen ND, Center JR, Eisman JA, Nguyen TV (2007) Bone loss, weight loss, and weight fluctuation predict mortality risk in elderly men and women. J Bone Miner Res 22:1147\u20131154","journal-title":"J Bone Miner Res"},{"key":"985_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","volume":"7","author":"P Hadji","year":"2017","unstructured":"Hadji P, Aapro MS, Body JJ, Gnant M, Brandi ML et al (2017) Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol 7:1\u201312","journal-title":"J Bone Oncol"},{"key":"985_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-017-0884-x","author":"K Nakatsukasa","year":"2017","unstructured":"Nakatsukasa K, Koyama H, Ouchi Y, Sakaguchi K, Fujita Y, Matsuda T, Kato M, Konishi E, Taguchi T (2017) Effect of denosumab administration on low bone mineral density (T-score \u2212\u20091.0 to \u2212\u20092.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer. J Bone Miner Metab. \n                    https:\/\/doi.org\/10.1007\/s00774-017-0884-x\n                    \n                  \n                           (Epub ahead of print)","journal-title":"J Bone Miner Metab"},{"key":"985_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-018-0917-0","author":"K Nakatsukasa","year":"2018","unstructured":"Nakatsukasa K, Koyama H, Ouchi Y, Sakaguchi K, Fujita Y, Matsuda T, Kato M, Konishi E, Taguchi T (2018) Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer. J Bone Miner Metab. \n                    https:\/\/doi.org\/10.1007\/s00774-018-0917-0\n                    \n                  \n                           (Epub ahead of print)","journal-title":"J Bone Miner Metab"},{"key":"985_CR14","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2147\/TCRM.S167579","volume":"14","author":"K Nakatsukasa","year":"2018","unstructured":"Nakatsukasa K, Koyama H, Ouchi Y, Sakaguchi K, Fujita Y, Matsuda T, Kato M, Konishi E, Taguchi T (2018) Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study. Ther Clin Risk Manag 14:1213\u20131218","journal-title":"Ther Clin Risk Manag"},{"key":"985_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-018-0896-y","author":"K Nakatsukasa","year":"2018","unstructured":"Nakatsukasa K, Koyama H, Ouchi Y, Ono H, Sakaguchi K et al (2018) The effect of denosumab on low bone mineral density (T-score \u2212\u20091.0 to \u2212\u20092.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results. Breast Cancer. \n                    https:\/\/doi.org\/10.1007\/s12282-018-0896-y\n                    \n                  \n                           (Epub ahead of print)","journal-title":"Breast Cancer"},{"key":"985_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","volume":"386","author":"M Gnant","year":"2015","unstructured":"Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R et al (2015) Adjuvant denosumab in breast cancer (ABCSG-18): a multicenter, randomized, double-blind, placebo-controlled trial. Lancet 386:433\u2013443","journal-title":"Lancet"},{"key":"985_CR17","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1200\/JCO.2008.16.3832","volume":"26","author":"GK Ellis","year":"2008","unstructured":"Ellis GK, Bone HG, Chlebowski R, Paul D, Spadfora S, Smith J, Jun S (2008) Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol 26:4875\u20134882","journal-title":"J Clin Oncol"},{"key":"985_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bone.2013.11.016","volume":"59","author":"RM Zebaze","year":"2014","unstructured":"Zebaze RM, Libanati C, Austin M, Ghasem-Zadeh A, Hanley DA, Zanchetta JR, Thomas T, Boutroy S, Bogado CE, Bilezikian JP, Seeman E (2014) Differing effects of denosumab and alendronate on cortical and trabecular bone. Bone 59:173\u2013179","journal-title":"Bone"},{"key":"985_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bone.2011.03.769","volume":"49","author":"PJ Kostenuik","year":"2011","unstructured":"Kostenuik PJ, Smith SY, Jolette J, Schroeder J, Pyrah I, Ominsky MS (2011) Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody. Bone 49:151\u2013161","journal-title":"Bone"},{"key":"985_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/8756-3282(95)00436-X","volume":"18","author":"JP Devogelaer","year":"1996","unstructured":"Devogelaer JP, Broll H, Correa-Rotter R, Cumming DC, De Deuxchaisnes CN et al (1996) Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3\u00a0years in postmenopausal women with osteoporosis. Bone 18:141\u2013150","journal-title":"Bone"},{"key":"985_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0002-9343(96)00282-3","volume":"101","author":"JR Tucci","year":"1996","unstructured":"Tucci JR, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora AC II (1996) Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101:488\u2013501","journal-title":"Am J Med"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-00985-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-018-00985-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-00985-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T11:34:20Z","timestamp":1571830460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-018-00985-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1007\/s00774-018-00985-8","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]},"assertion":[{"value":"7 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}